Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Verhaeghe

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Shock (Augusta, Ga.)|September 26, 1997
Treatment with a platelet-activating factor antagonist has little protective effects during endotoxic shock in the dogH Spapen, H Zhang, V Verhaeghe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2024
Oral health care pathways for patients with epidermolysis bullosa: A position statement from the European reference network for rare skin diseasesS Krämer, A L Hillebrecht, K Bekes, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Shock (Augusta, Ga.)|September 26, 1997
Treatment with a platelet-activating factor antagonist has little protective effects during endotoxic shock in the dogH Spapen, H Zhang, V Verhaeghe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2024
Oral health care pathways for patients with epidermolysis bullosa: A position statement from the European reference network for rare skin diseasesS Krämer, A L Hillebrecht, K Bekes, et al.
Pageof 2